KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Globus Medical (GMED) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $3.8 million.

  • Globus Medical's Other Non Operating Income fell 6303.14% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.2 million, marking a year-over-year increase of 41337.51%. This contributed to the annual value of -$43.3 million for FY2024, which is 40356.27% down from last year.
  • As of Q3 2025, Globus Medical's Other Non Operating Income stood at $3.8 million, which was down 6303.14% from $110.6 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Other Non Operating Income registered a high of $110.6 million during Q2 2025, and its lowest value of -$37.5 million during Q4 2024.
  • Moreover, its 5-year median value for Other Non Operating Income was $2.6 million (2021), whereas its average is $6.0 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first crashed by 41480.34% in 2022, then soared by 1099327.98% in 2025.
  • Quarter analysis of 5 years shows Globus Medical's Other Non Operating Income stood at $1.6 million in 2021, then plummeted by 414.8% to -$5.1 million in 2022, then soared by 488.45% to $19.9 million in 2023, then plummeted by 288.32% to -$37.5 million in 2024, then surged by 110.14% to $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q3 2025, $110.6 million for Q2 2025, and $4.3 million during Q1 2025.